John Mulcahy
Amministratore Delegato presso SiteOne Therapeutics, Inc.
Posizioni attive di John Mulcahy
Società | Posizione | Inizio | Fine |
---|---|---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Amministratore Delegato | 23/03/2021 | - |
Fondatore | 01/01/2010 | - | |
Presidente | 23/03/2021 | - | |
Direttore Tecnico/Scientifico/R&S | 01/01/2010 | 23/03/2021 |
Storia della carriera di John Mulcahy
Formazione di John Mulcahy
Harvard University | Undergraduate Degree |
Stanford University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Health Technology |
- Borsa valori
- Insiders
- John Mulcahy
- Esperienza